563 Tacloban City Jail inmates fully vaxxed vs COVID-19 | Inquirer News

563 Tacloban City Jail inmates fully vaxxed vs COVID-19

/ 06:17 PM October 02, 2021

Tacloban City Jail COVID vaccine

TACLOBAN CITY, Philippines — All 563 inmates at the Tacloban City Jail are now fully vaccinated.

The inmates had their first dose last Sept. 3 and were given their second dose of the vaccine on Friday, October 1.

Article continues after this advertisement

The vaccination of the inmates is part of the mobile vaccination campaign of the Tacloban City government as pushed by Mayor Alfred Romualdez.

FEATURED STORIES

The mobile vaccination campaign also visits different barangays and the city public market.

So far, 59,114 city residents have received their first dose. At least 52,194 have been fully vaccinated.

As of Saturday, Tacloban City has 180 active cases of COVID-19. Since the start of the pandemic, the city recorded 5,718 COVID-19 cases; 5,392 recoveries, and 128 deaths.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Vaccination

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.